Wolf Gunter, Wenzel Ulrich, Jablonski Katharina, Brundert May, Rinninger Franz
Department of Medicine, University of Jena, Germany.
Nephrol Dial Transplant. 2005 Jun;20(6):1222-7. doi: 10.1093/ndt/gfh727.
The kidney plays an important role in the metabolism of lipoproteins, but renal cells are also a target of lipids under pathophysiological conditions contributing to organ damage and progression of disease. The majority of studies has focused on the interaction of renal cells with low-density lipoproteins. Relatively little is known of potential metabolism of high-density lipoproteins (HDL) on renal cells However, diverse pathophysiological situations, such as the nephrotic syndrome and acute renal injury, may be associated with an activated renin-angiotensin system as well as altered renal handling of HDL. Therefore, the present study sought to gain insight into the expression of the HDL receptor scavenger receptor class B type I (SR-BI) in cultured renal cells and a potential regulation by angiotensin II (ANG II).
Different renal cells lines and primary cultures (proximal tubular and mesangial cells) were screened by western blot for the expression of SR-BI. MCT cells, a mouse proximal tubular cell line, were selected for further studies. SR-BI protein and mRNA expression were determined after treatment with various doses of ANG II in the presence or absence of AT(1)- or AT(2)-receptor blocker. Uptake of HDL-associated cholesteryl ester into MCT cells was determined. Finally, rats were infused intraperitoneally with ANG II for 3-7 days, proximal tubules were isolated by differential centrifugation and SR-BI protein expression was assessed. Results. SR-BI protein was expressed in various primary cultures and permanent renal cell lines. ANG II (10(-10)-10(-6) M) treatment for 24 h induced a significant down-regulation of SR-BI protein and mRNA expression in MCT cells. This suppression was attenuated by an AT(1)-receptor antagonist whereas an AT(2)-blocker was without effect. MCT cells revealed a high selective uptake of HDL cholesteryl ester that was significantly higher than that in syngeneic mesangial cells. ANG II for 24 h significantly reduced this selective HDL cholesteryl ester uptake into MCT, but not mesangial cells. Finally, ANG II- infusion into rats for 3 and 7 days induced a significant decrease of SR-BI protein expression in isolated tubules.
Our data show that ANG II mediates down-regulation of SR-BI expression on proximal tubular cells in vivo and in vitro. However, the effects were small and additional experiments are necessary to confirm these first observations. The attenuated SR-BI expression is functionally relevant and associated with a decrease in cholesteryl ester uptake. ANG II-mediated suppression may contribute to various pathophysiological situations, such as acute tubular injury, the nephrotic syndrome and atherosclerosis.
肾脏在脂蛋白代谢中起重要作用,但在病理生理条件下,肾细胞也是脂质的作用靶点,这会导致器官损伤和疾病进展。大多数研究集中于肾细胞与低密度脂蛋白的相互作用。关于高密度脂蛋白(HDL)在肾细胞上的潜在代谢了解相对较少。然而,多种病理生理情况,如肾病综合征和急性肾损伤,可能与肾素 - 血管紧张素系统激活以及HDL的肾脏处理改变有关。因此,本研究旨在深入了解培养的肾细胞中HDL受体B类I型清道夫受体(SR - BI)的表达以及血管紧张素II(ANG II)对其的潜在调节作用。
通过蛋白质免疫印迹法筛选不同的肾细胞系和原代培养细胞(近端肾小管细胞和系膜细胞)中SR - BI的表达。选择小鼠近端肾小管细胞系MCT细胞进行进一步研究。在存在或不存在AT(1)或AT(2)受体阻滞剂的情况下,用不同剂量的ANG II处理后,测定SR - BI蛋白和mRNA表达。测定HDL相关胆固醇酯进入MCT细胞的摄取情况。最后,给大鼠腹腔注射ANG II 3 - 7天,通过差速离心分离近端肾小管并评估SR - BI蛋白表达。结果:SR - BI蛋白在各种原代培养细胞和永久性肾细胞系中均有表达。用ANG II(10(-10)-10(-6) M)处理24小时可诱导MCT细胞中SR - BI蛋白和mRNA表达显著下调。这种抑制作用可被AT(1)受体拮抗剂减弱,而AT(2)受体阻滞剂则无作用。MCT细胞对HDL胆固醇酯有高度选择性摄取,显著高于同基因系膜细胞。ANG II处理24小时可显著降低MCT细胞对HDL胆固醇酯的这种选择性摄取,但对系膜细胞无影响。最后,给大鼠腹腔注射ANG II 3天和7天可导致分离的肾小管中SR - BI蛋白表达显著降低。
我们的数据表明,ANG II在体内和体外均可介导近端肾小管细胞上SR - BI表达的下调。然而,这种作用较小,需要进一步实验来证实这些初步观察结果。SR - BI表达减弱在功能上是相关的,并且与胆固醇酯摄取减少有关。ANG II介导的抑制作用可能导致各种病理生理情况,如急性肾小管损伤、肾病综合征和动脉粥样硬化。